Jorge Castillo
MD
Clinical Director, Bing Center for Waldenstrom's Macroglobulinemia
👥Biography 个人简介
Jorge Castillo is a leading WM clinician who has led key clinical trials including the ASPEN trial comparing zanubrutinib to ibrutinib in WM, demonstrating superior tolerability with comparable efficacy for zanubrutinib. His research addresses frontline, maintenance, and relapsed WM treatment strategies and the impact of genetic subtypes on outcomes. He contributes to international WM consensus guidelines and has educated the oncology community through numerous review publications.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jorge Castillo 的研究动态
Follow Jorge Castillo's research updates
留下邮箱，当我们发布与 Jorge Castillo（Dana-Farber Cancer Institute / Harvard Medical School）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment